Existing treatment strategies: Does noncompliance make a difference?

Journal of Hypertension, Supplement

Volumn 16, Issue 7, 1998, Pages

  Caro, J Jaime ^a   Speckman, Jeanne L ^a  

^a CARO RESEARCH INSTITUTE   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin II receptor antagonists; Antihypertensives; Beta blockers; Blood pressure control; Calcium channel blockers; Diuretics; Patient compliance

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; BEHAVIOR; BLOOD PRESSURE REGULATION; CANADA; CONFERENCE PAPER; DRUG SAFETY; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 0031721574     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
2. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1997; 157:2413-2446.
3. Black DM, Brand RJ, Greeenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. J Gerontol 1987; 42:552-557.
4. Hershey JC, Morton BG, Davis JB, Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health 1980; 70:1081-1089.
5. Nelson EC, Stason WB, Neutra RR, Solomon HS, McArdle PJ. Impact of patient perceptions on compliance with treatment for hypertension. Med Care 1978; 16:893-906.
6. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan SF. Underutilization of antihypertensive drugs and associated hospitalization. Med Care 1989; 27:1159-1166.
7. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994; 32:214-226.
8. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S, on behalf of the HAN E Trial Research Group. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ 1997; 315:154-159.
9. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311:293-295.
10. Bailey JE, Lee MD, Somes GW, Graham RL. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther 1996; 18:1252-1262.
11. Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clin Ther 1997; 19:1433-1445.
12. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10:697-704.
13. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997; 35:1164-1170.
14. Caro JJ. Stepped care for hypertension: are the assumptions valid? J Hypertens 1997; 15 (suppl 7):S35-S39.
15. Caro JJ, Salas M, Speckman JL, Raggio GD, Jackson JD. Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1998 (in press).
16. Williams GH. Hypertensive vascular disease. In: Harrison's Principles of Internal Medicine. Isselbacher KJ, Braunwald E et al. (editors). New York: McGraw-Hill Inc.; 1994.
17. Simon TA, Gelardon T, Freitag SA, Kassler-Taub KB, Davies R. Safety of irbesartan in the treatment of mild to moderate systemic hypertension. Am J Cardiol 1998; 82:179-182.